Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Claya vs TrimRx

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.0

Claya

Best for compounded GLP-1 in injectable and oral-tablet forms with named clinicians
★★★3.5

Starting at $179/mo

CompoundedOral OptionSemaglutideTirzepatide
Visit Claya
9.0

TrimRx

Best for best overall value
★★★★4.5

Starting at $199/mo

CompoundedSemaglutideTirzepatide
Visit TrimRx

Side-by-Side Comparison

FeatureClayaTrimRx
Overall Score7.0/109.0/10
Starting Price$179/mo$199/mo
Editorial Rating3.5 ★ /54.5 ★ /5
Features7 features3 features
States Available00
Compounded✓ Yes✓ Yes
Brand Name
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

Claya

Pros

  • Two named licensed clinicians (Habashy, NMD MS and Barber, MD PhD) — rare transparency for compounded GLP-1
  • Two named pharmacy partners with full addresses (RedRock, UT and Healthware, KY)
  • Both injectable and oral-tablet forms offered for semaglutide and tirzepatide
  • Weight-loss money-back guarantee published on the homepage
  • Free expedited shipping included in the monthly price

Cons

  • States-served list not disclosed — you must check at checkout
  • LegitScript certification status not displayed
  • Corporate legal entity not disclosed on the site or privacy policy
  • Oral compounded tablets have weaker efficacy data than injectable semaglutide
  • Intro pricing is higher at refill ($299), erasing the first-month advantage

TrimRx

Pros

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Cons

  • Limited public information on program details

Our Verdict

Winner: TrimRxScore: 9.0/10

TrimRx edges out Claya with a higher overall score of 9.0/10 and is particularly strong for best overall value. Claya remains a solid alternative, especially if you're looking for compounded GLP-1 in injectable and oral-tablet forms with named clinicians.

Glossary references

Key terms in this article, linked to their canonical definitions.

Related comparisons

Continue exploring Claya and TrimRx head-to-heads in the same category.

Or see the full category ranking.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.